Mostrar el registro sencillo del ítem

Structural and functional computational analysis of nicotine analogs as potential neuroprotective compounds in Parkinson disease

dc.contributor.authorBecerra G.P.
dc.contributor.authorRojas-Rodríguez F.
dc.contributor.authorRamírez D.
dc.contributor.authorLoaiza A.E.
dc.contributor.authorTobar-Tosse F.
dc.contributor.authorMejía S.M.
dc.contributor.authorGonzález J.
dc.date.accessioned2020-09-02T22:13:03Z
dc.date.available2020-09-02T22:13:03Z
dc.date.issued2020
dc.identifier10.1016/j.compbiolchem.2020.107266
dc.identifier.citation86, , -
dc.identifier.issn14769271
dc.identifier.urihttps://hdl.handle.net/20.500.12728/3714
dc.descriptionAs the mechanism of interaction between nicotinic receptors with nicotine analogs is not yet fully understood, information at molecular level obtained from computational calculations is needed. In this sense, this work is a computational study of eight nicotine analogs, all with pyrrolidine ring modifications over a nicotine-based backbone optimized with B3LYP-D3/aug-cc-pVDZ. A molecular characterization was performed focusing on geometrical parameters such as pseudo-rotation angles, atomic charges, HOMO and LUMO orbitals, reactivity indexes and intermolecular interactions. Three analogs, A2 (3-(1,3-dimethyl-4,5-dihydro-1h-pirazole-5-yl) pyridine), A3 (3-(3-methyl-4,5-dihydro-1H-pyrazol-5-yl)-pyridine) and A8 (5-methyl-3-(pyridine-3-yl)-4,5-dihydroisoxazole), were filtered suggesting putative neuroprotective activity taking into account different reactivity values, such as their lowest hardness: 2.37 eV (A8), 2.43 eV (A2) and 2.56 eV (A3), compared to the highest hardness value found: 2.71 eV for A5 (3-((2S,4R)-4-(fluoromethyl)-1-methylpyrrolidine-2-il) pyridine), similar to the value of nicotine (2.70 eV). Additionally, molecular docking of all 8 nicotine analogs with the α 7 nicotinic acetylcholine receptor (α 7 nAChR) was performed. High values of interaction between the receptor and the three nicotine analogs were obtained: A3 (-7.1 kcal/mol), A2 (-6.9 kcal/mol) and A8 (-6.8 kcal/mol); whereas the affinity energy of nicotine was -6.4 kcal/mol. Leu116 and Trp145 are key residues in the binding site of α 7 nAChR interacting with nicotine analogs. Therefore, based upon these results, possible application of these nicotine analogs as neuroprotective compounds and potential implication at the design of novel Parkinson's treatments is evidenced. © 2020 The Authors
dc.language.isoen
dc.publisherElsevier Ltd
dc.subjectDFT calculations
dc.subjectMolecular Orbitals
dc.subjectNatural Bond Orbitals
dc.subjectNeurodegenerative Diseases
dc.subjectNicotine analogs
dc.subjectGeometry
dc.subjectHardness
dc.subjectPyridine
dc.subjectComputational analysis
dc.subjectComputational calculations
dc.subjectComputational studies
dc.subjectIntermolecular interactions
dc.subjectMolecular characterization
dc.subjectNeuroprotective activity
dc.subjectNicotinic acetylcholine receptors
dc.subjectReactivity indices
dc.subjectNicotine
dc.titleStructural and functional computational analysis of nicotine analogs as potential neuroprotective compounds in Parkinson disease
dc.typeArticle


Ficheros en el ítem

Thumbnail
Nombre:
item_2-s2.0-85084932476.pdf
Tamaño:
3.072Kb
Formato:
PDF
Ver/

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem